Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHE/300529 stock hub

SHE/300529 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300529is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.1B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300529

In the news

Latest news · SHE/300529

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.1

P25 17.1P50 24.2P75 37.8

Trailing P/E26.4

P25 23.5P50 41.3P75 83.2

ROE15.6

P25 -0.9P50 4.1P75 8.8

ROIC26.7

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300529 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

CNY

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,301
Employees Change	-496%
Employees Change Percent	-17.73
Enterprise value	CNY 13.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Isin	CNE100002995
Last refreshed	2026-05-10
Market cap	CNY 15.1B
Price	CNY 19.51
Price currency	CNY
Rev Per Employee	879,880.75x
Sector	Healthcare
Sic	3842
Symbol	she/300529
Website	https://www.jafroninternational.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.74%
EV Earnings	24.3x
EV/EBIT	18.56x
EV/EBITDA	16.01x
EV/FCF	25.15x
EV/Sales	6.78x
FCF yield	3.61%
Forward P/E	24.09x
P/B ratio	4.08x
P/E ratio	26.4x
P/S ratio	7.46x
PE Ratio10 Y	47.94x
PE Ratio3 Y	32.5x
PE Ratio5 Y	34.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	36.5%
EBITDA Margin	42.21%
FCF margin	26.94%
Gross margin	77.16%
Gross Profit	CNY 1.6B
Gross Profit Growth	-22.42%
Gross Profit Growth Q	-2.08%
Gross Profit Growth3 Y	-6.68%
Gross Profit Growth5 Y	-3.13%
Net Income	CNY 564.6M
Net Income Growth	-22.05%
Net Income Growth Q	16.81%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-9.07%
Net Income Growth5 Y	-10.34%
Pretax Margin	34.33%
Profit Margin	27.88%
Profit Per Employee	CNY 245,350
Profitable Years	15
ROA	8.24
Roa5y	11.41
ROCE	14.29
ROE	15.6
Roe5y	23.42
ROIC	26.66
Roic5y	34.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-6.71%
Cagr3y	-10.44%
Cagr5y	-25.18%
Div CAGR3	-3.85%
Div CAGR5	-2.33%
EPS Growth	-20.03
EPS Growth Q	21.74
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-7.87
EPS Growth5 Y	-9.23
FCF Growth	-12.22%
FCF Growth Q	-1.51%
FCF Growth3 Y	-4.69%
FCF Growth5 Y	-0.31%
OCF Growth	-12.9%
OCF Growth Q	-4.89%
OCF Growth10 Y	13.78%
OCF Growth3 Y	-10.72%
OCF Growth5 Y	-7.45%
Revenue Growth	-18.39x
Revenue Growth Q	2.33x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-5.07x
Revenue Growth5 Y	-1.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.36
Assets	CNY 5.5B
Cash	CNY 2.6B
Current Assets	CNY 3B
Current Liabilities	CNY 348.6M
Debt	CNY 1.2B
Debt EBITDA	CNY 1.45
Debt Equity	CNY 0.34
Debt FCF	CNY 2.28
Equity	CNY 3.7B
Interest Coverage	14.32
Liabilities	CNY 1.8B
Long Term Assets	CNY 2.5B
Long Term Liabilities	CNY 1.5B
Net Cash	CNY 1.4B
Net Cash By Market Cap	CNY 9.2
Net Cash Growth	18.03%
Net Debt EBITDA	CNY -1.63
Net Debt Equity	CNY -0.38
Net Debt FCF	CNY -2.55
Tangible Book Value	CNY 3.6B
Tangible Book Value Per Share	CNY 4.56
WACC	6.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.71
Inventory Turnover	1.54
Net Working Capital	CNY 66M
Quick ratio	7.75
Working Capital	CNY 2.7B
Working Capital Turnover	CNY 0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.52%
Dividend Growth	100%
Dividend Growth Years	1%
Dividend per share	CNY 0.52
Dividend Years	9
Dividend Yield	2.67%
Ex Div Date	2025-05-26
Last Dividend	CNY 0.8
Payout Frequency	Annual
Payout Ratio	113.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-6.71%
200-day SMA	20.81
3Y total return	-28.18%
50-day SMA	18.45
50-day SMA vs 200-day SMA	50under200
5Y total return	-76.54%
All Time High	103
All Time High Change	-81.06%
All Time High Date	2021-05-21
All Time Low	6.82
All Time Low Change	186.03%
All Time Low Date	2016-08-02
ATR	0.46
Beta	0.45
Beta1y	0.35
Beta2y	0.56
Ch YTD	-0.81
High	19.62
High52	24.98
High52 Date	2025-07-30
High52ch	-21.9%
Low	19.1
Low52	17.27
Low52 Date	2026-04-07
Low52ch	12.97%
Ma50ch	5.75%
Price vs 200-day SMA	-6.24%
RSI	63.43
RSI Monthly	39.28
RSI Weekly	48.38
Sharpe ratio	-0.44x
Sortino ratio	-0.41
Total Return	5.18%
Tr YTD	-0.81
Tr1m	12.71%
Tr1w	0.93%
Tr3m	-4.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 739M
Operating Income Growth	-16.9
Operating Income Growth Q	12.92
Operating Income Growth3 Y	-1.26
Operating Income Growth5 Y	-7.18
Operating margin	36.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	374,607,816%
Net Borrowing	-156,387,598
Shares Insiders	50.93%
Shares Institutions	8.93%
Shares Out	774,362,555
Shares Qo Q	0.42%
Shares Yo Y	-2.52%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 545.3M
Average Volume	5,862,465.9x
Bv Per Share	4.7
CAPEX	CNY -162.7M
Ch1m	12.71
Ch1w	0.93
Ch1y	-10.05
Ch3m	-4.88
Ch3y	-33.32
Ch5y	-78.79
Ch6m	-4.46
Change	1.88%
Change From Open	2.09
Close	19.15
Days Gap	-0.21
Depreciation Amortization	115,475,610
Dollar Volume	127,679,488.1
Earnings Date	2026-04-28
EBIT	CNY 739M
EBITDA	CNY 854.5M
EPS	CNY 0.74
F Score	5
FCF	CNY 545.3M
FCF EV Yield	3.98x
FCF Per Share	CNY 0.7
Financing CF	-662,852,208
Fiscal Year End	December
Founded	1,989
Goodwill	7,010,722
Graham Number	8.83845
Graham Upside	-54.7
Income Tax	CNY 130.9M
Investing CF	-22,325,365
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2020-05-20
Last Split Type	Forward
Lynch Fair Value	CNY 3.7
Lynch Upside	-81.06
Ma150	19.93
Ma150ch	-2.11%
Ma20	18.31
Ma20ch	6.58%
Net CF	19,187,437
Next Earnings Date	2026-08-07
Open	19.11
P FCF Ratio	27.7
P OCF Ratio	21.34
Payment Date	2025-05-26
Position In Range	78.85
Ppne	1,890,216,940
Price Date	2026-05-08
Price EBITDA	CNY 17.68
Ptbv Ratio	4.2
Relative Volume	1.16x
Revenue	2,024,605,606x
Tax By Revenue	6.46x
Tax Rate	18.83%
Tr6m	-4.46%
Volume	6,544,310
Z Score	7.64

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300529 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$0.52 annual per share

Payout ratio

+113.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-2.3%

1 consecutive years of growth

Total shareholder yield

+5.2%

Next ex-dividend date: 2025-05-26

Performance

SHE/300529 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300529?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.9%

Share of float held by funds and institutions

Insider ownership

+50.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.5%

Negative means the company is buying back shares.

Technical

SHE/300529 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.4

Neutral momentum band

Price vs 200-day MA

-6.2%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

-0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300529

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300529 stock rating?

she/300529 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300529 analysis?

The full report lives at /stocks/she/300529/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300529?

The latest report frames she/300529 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300529 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.